Is SYNBIOTIC SE halal to invest in?

According to Musaffa's Shariah screening methodology, SYNBIOTIC SE (SBX.DE) is currently classified as NOT HALAL as of January 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is SYNBIOTIC SE a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes SYNBIOTIC SE using these criteria to determine its compliance status.

Can Muslims buy shares of SYNBIOTIC SE?

Muslim investors may consider investing in SYNBIOTIC SE if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is SYNBIOTIC SE classified as NOT HALAL?

Musaffa determines the Shariah status of SYNBIOTIC SE by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for SYNBIOTIC SE updated?

The Shariah compliance status of SYNBIOTIC SE may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like SYNBIOTIC SE become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of SYNBIOTIC SE?

You can check the latest Shariah compliance status of SYNBIOTIC SE on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

SYNBIOTIC SE SBX.DE

€1.83 €0.13 (7.53%) 1D

Last Updated: May 15, 12:00 AM·XETRA

SBX.DE Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: January 20, 2026

Report Source: 2025 2nd Quarter Report

SYNBIOTIC SE. Stock Analysis SBX.DE

Germany Health Care Nano Cap Report: Q2, 2025

SynBiotic SE operates as a cannabis company, which engages in the research and development of cannabinoid and terpene-based solutions. The company is headquartered in Munich, Bayern and currently employs 79 full-time employees. The company went IPO on 2021-05-13. The firm operates in the industrial hemp and cannabis market. The company invests in ventures across the value chain from cultivation and research to development (R&D), production, sales, and distribution of cannabinoid-based products. This includes pharmaceuticals, cosmetics, nutrition and supplements as well as lifestyle products. Its main focus is in the development of medical cannabis and industrial hemp markets. Medical cannabis is used for therapeutic applications with patients. Industrial hemp is used to manufacture products such as fibres, seeds, stalks, shives, and oils across various industries. The firm's major brands include Hempamed, The Hempany, Hempamed Rx among others.

Key Statistics of SYNBIOTIC SE (SBX.DE)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€1.70€1.84

Today's Open

€1.70

Volume

5487.00

P/E Ratio (TTM)

52 Week Range

€1.51€3.85

Market Cap

13.62M

Avg. Volume

8411.19

Dividend Yield

Financial Metrics & Statements of SYNBIOTIC SE (SBX.DE)

FAQ's for SYNBIOTIC SE (SBX.DE)

According to Musaffa’s Shariah screening methodology, SYNBIOTIC SE (SBX.DE) is currently classified as NOT HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.